Clinical Trials for Newly Diagnosed Parkinson's

Being newly diagnosed with Parkinson's is overwhelming, but it is also the stage when the most clinical trials are open to you. Many disease-modifying studies — the ones testing whether a treatment can slow Parkinson's down — specifically look for people in the first few years after diagnosis, before symptoms have advanced.

These trials often use phrases like "early-stage", "de novo", "newly diagnosed", or "within 2 years of diagnosis" in who they can enroll. Some also look for people who have not yet started medication, which we track on a separate page.

Below are the recruiting trials we track that are open to people in the early stages of Parkinson's. Sign up to be emailed when a new one opens.

56 Recruiting Newly Diagnosed Trials

Related Topics

Browse all recruiting Parkinson's trials